Document is current
Any future updates will be listed below
-
Authors
Mehta, Darshan
Paradkar, Akshay
Nayak, Prakash
Rekhi, Bharat
Mohanty, Bhabani
Chaudhari, Pradip
Waghmare, Sanjeev K https://orcid.org/0000-0002-3693-5620
-
Funding
Funding for this research was provided by:
Advanced Centre for Treatment, Research and Education in Cancer (Department of Atomic Energy, INDIA 4598)
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) - Khargar
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 1 April 2025
First Online: 25 May 2025
Declarations
:
: The authors declare no competing interests. The authors have no relevant financial or non-financial interests to disclose. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: The cell line ACSCC1 was established from the cutaneous SCC cancer patient samples from Tata Memorial Hospital (Mumbai, India). This study was performed in line with the principles of Helsinki. Approval was granted by the Institutional Human Ethics Committee, ACTREC (Dated June 21st 2023– IEC #900939). The Institutional Animal Ethics Committee (IAEC), ACTREC has approved all the animal experiments. We have adhered to the CPSEA criteria set by the Indian Ministry of Environment and Forests for conducting all animal research. In addition, we adhered to the Arrive criteria and the requirements for care and animal welfare set by the National Research Council in Washington, DC. (July 2023- IAEC 20/2023).
: Informed consent was obtained from all the individual participants included in the study. The Institutional Human Ethics Committee, ACTREC has approved this study.
: The authors affirm that human research participants provided informed consent for the publication of the images in this manuscript.
